CLINICAL_TRIALS ClinicalTrials.gov record update

Assess Immunogenicity, Reactogenicity of GSK Biologicals'-dTpa-IPV Vaccine Versus dTpa & IPV Vaccines Administered Separately & Compared With Aventis Pasteur MSD's Td-IPV Vaccine When Administered to Healthy Adolescents & Adults

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01277705
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:07.637681+00:00
Published At: 2016-09-07T00:00:00+00:00
Record Updated At: 2016-09-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Tetanus", "Diphtheria", "Acellular Pertussis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-09-07"
protocolSection.identificationModule.nctId: "NCT01277705"
protocolSection.identificationModule.officialTitle: "Assess Immunogenicity, Reactogenicity of GSK Biologicals\u0027-dTpa-IPV Vaccine Versus dTpa \u0026 IPV Vaccines Administered Separately \u0026 Compared With Aventis Pasteur MSD\u0027s Td-IPV Vaccine When Administered to Healthy Adolescents \u0026 Adults"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.